• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠化疗诱导的肠道损伤后的肠道适应性取决于胰高血糖素样肽-2受体激活。

Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation.

作者信息

Billeschou Anna, Hunt Jenna Elizabeth, Ghimire Aruna, Holst Jens J, Kissow Hannelouise

机构信息

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.

NNF Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.

出版信息

Biomedicines. 2021 Jan 7;9(1):46. doi: 10.3390/biomedicines9010046.

DOI:10.3390/biomedicines9010046
PMID:33430185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7825593/
Abstract

Intestinal adaptation is an important response and a natural repair mechanism in acute intestinal injury and is critical for recovery. Glucagon-like peptide 2 (GLP-2) has been demonstrated to enhance mucosal repair following intestinal damage. In this study, we aimed to investigate the role of GLP-2 receptor activation on intestinal protection and adaptation upon chemotherapy-induced intestinal injury. The injury was induced with a single injection of 5-fluorouracil in female GLP-2 receptor knockout (GLP-2R(-/-)) mice and their wild type (WT) littermates. The mice were euthanized in the acute or the recovery phase of the injury; the small intestines were analysed for weight changes, morphology, histology, inflammation, apoptosis and proliferation. In the acute phase, only inflammation was slightly increased in the GLP-2R(-/-) mice compared to WT. In the recovery phase, we observed the natural compensatory response with an increase in small intestinal weight, crypt depth and villus height in WT mice, and this was absent in the GLP-2R(-/-) mice. Both genotypes responded with hyperproliferation. From this, we concluded that GLP-2R signalling does not have a major impact on acute intestinal injury but is pivotal for the adaptive response in the small intestine.

摘要

肠道适应性是急性肠道损伤中的一种重要反应和自然修复机制,对恢复至关重要。胰高血糖素样肽2(GLP-2)已被证明可增强肠道损伤后的黏膜修复。在本研究中,我们旨在探讨激活GLP-2受体对化疗诱导的肠道损伤时肠道保护和适应性的作用。通过单次注射5-氟尿嘧啶诱导雌性GLP-2受体敲除(GLP-2R(-/-))小鼠及其野生型(WT)同窝小鼠产生损伤。在损伤的急性期或恢复期对小鼠实施安乐死;分析小肠的重量变化、形态、组织学、炎症、凋亡和增殖情况。在急性期,与WT小鼠相比,GLP-2R(-/-)小鼠仅炎症略有增加。在恢复期,我们观察到WT小鼠出现小肠重量增加、隐窝深度和绒毛高度增加的自然代偿反应,而GLP-2R(-/-)小鼠则无此反应。两种基因型均出现增殖过度。由此我们得出结论,GLP-2R信号传导对急性肠道损伤没有重大影响,但对小肠的适应性反应至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/60c298111650/biomedicines-09-00046-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/5c80bb22ce85/biomedicines-09-00046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/720512a84669/biomedicines-09-00046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/2a3eede2cbb2/biomedicines-09-00046-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/e1a57eb698d8/biomedicines-09-00046-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/60c298111650/biomedicines-09-00046-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/5c80bb22ce85/biomedicines-09-00046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/720512a84669/biomedicines-09-00046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/2a3eede2cbb2/biomedicines-09-00046-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/e1a57eb698d8/biomedicines-09-00046-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb0/7825593/60c298111650/biomedicines-09-00046-g005.jpg

相似文献

1
Intestinal Adaptation upon Chemotherapy-Induced Intestinal Injury in Mice Depends on GLP-2 Receptor Activation.小鼠化疗诱导的肠道损伤后的肠道适应性取决于胰高血糖素样肽-2受体激活。
Biomedicines. 2021 Jan 7;9(1):46. doi: 10.3390/biomedicines9010046.
2
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.内源性胰高血糖素样肽-1 和 2 对于小鼠急性肠损伤后的再生是必需的。
PLoS One. 2018 Jun 4;13(6):e0198046. doi: 10.1371/journal.pone.0198046. eCollection 2018.
3
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.胰高血糖素样肽-1 治疗化疗引起的黏膜炎。
Gut. 2013 Dec;62(12):1724-33. doi: 10.1136/gutjnl-2012-303280. Epub 2012 Oct 20.
4
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.外源性胰高血糖素样肽-2(GLP-2)可预防大鼠小肠化疗引起的黏膜炎。
Cancer Chemother Pharmacol. 2012 Jul;70(1):39-48. doi: 10.1007/s00280-012-1882-2. Epub 2012 May 22.
5
Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.肠上皮胰岛素样生长因子-1 受体缺失后,胰高血糖素样肽-2 诱导的增殖丧失。
Gastroenterology. 2011 Dec;141(6):2166-2175.e7. doi: 10.1053/j.gastro.2011.09.014. Epub 2011 Sep 16.
6
Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.肠道黏膜对肠内营养物质的适应性依赖于胰高血糖素样肽-2在小鼠体内的生理作用。
Gastroenterology. 2005 May;128(5):1340-53. doi: 10.1053/j.gastro.2005.02.033.
7
Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.胰高血糖素样肽-2诱导残端空肠产生特定的适应性变化模式。
Dig Dis Sci. 2006 Sep;51(9):1557-66. doi: 10.1007/s10620-006-9077-5. Epub 2006 Aug 22.
8
Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.胶质细胞源性神经营养因子家族受体α2在胰高血糖素样肽对小鼠肠道作用中的角色
Am J Physiol Gastrointest Liver Physiol. 2007 Aug;293(2):G461-8. doi: 10.1152/ajpgi.00424.2006. Epub 2007 Jun 21.
9
Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.胰高血糖素样肽-2可诱导肠内营养的短肠综合征大鼠发生肠道适应性改变。
Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G964-72. doi: 10.1152/ajpgi.00509.2003. Epub 2004 Feb 12.
10
ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.ErbB 活性将胰高血糖素样肽-2 受体与再喂养诱导的小鼠小肠适应联系起来。
Gastroenterology. 2010 Jun;138(7):2447-56. doi: 10.1053/j.gastro.2010.03.006. Epub 2010 Mar 10.

引用本文的文献

1
Positive effects of selenized-oligochitosan on zearalenone-induced intestinal dysfunction in piglets.硒化壳寡糖对玉米赤霉烯酮诱导的仔猪肠道功能障碍的积极作用。
Front Vet Sci. 2023 May 16;10:1184969. doi: 10.3389/fvets.2023.1184969. eCollection 2023.
2
Evaluation and validation of chemotherapy-specific diarrhoea and histopathology in rats.评估和验证大鼠化疗相关性腹泻与组织病理学。
Basic Clin Pharmacol Toxicol. 2022 Dec;131(6):536-546. doi: 10.1111/bcpt.13790. Epub 2022 Sep 30.
3
Regulation of body weight: Lessons learned from bariatric surgery.

本文引用的文献

1
Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.TGR5 激动剂通过 GLP-2 依赖途径促进小鼠肠道生长。
Am J Physiol Gastrointest Liver Physiol. 2020 May 1;318(5):G980-G987. doi: 10.1152/ajpgi.00062.2020. Epub 2020 Apr 20.
2
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis.使用化疗诱导的粘膜炎小鼠模型评估小肠损伤和适应性的重要终点及增殖标志物
J Vis Exp. 2019 May 12(147). doi: 10.3791/59236.
3
Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function.
体重调节:减重手术的经验教训。
Mol Metab. 2023 Feb;68:101517. doi: 10.1016/j.molmet.2022.101517. Epub 2022 May 26.
4
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?二肽基肽酶-IV 抑制作用能否为恶性疾病的治疗干预提供新途径?
Cancers (Basel). 2022 Apr 21;14(9):2072. doi: 10.3390/cancers14092072.
5
Zearalenone Affect the Intestinal Villi Associated with the Distribution and the Expression of Ghrelin and Proliferating Cell Nuclear Antigen in Weaned Gilts.玉米赤霉烯酮影响断奶母猪肠道绒毛与Ghrelin 和增殖细胞核抗原分布和表达的关系。
Toxins (Basel). 2021 Oct 19;13(10):736. doi: 10.3390/toxins13100736.
6
Actions of glucagon-like peptide-1 receptor ligands in the gut.胰高血糖素样肽-1 受体配体在肠道中的作用。
Br J Pharmacol. 2022 Feb;179(4):727-742. doi: 10.1111/bph.15611. Epub 2021 Aug 4.
7
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies.化疗药物诱导的肠道黏膜炎:病理生理学及潜在治疗策略
Front Pharmacol. 2021 May 4;12:681417. doi: 10.3389/fphar.2021.681417. eCollection 2021.
胰高血糖素样肽-2 与肠道生长和功能的调节。
Compr Physiol. 2018 Jun 18;8(3):1185-1210. doi: 10.1002/cphy.c170055.
4
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.内源性胰高血糖素样肽-1 和 2 对于小鼠急性肠损伤后的再生是必需的。
PLoS One. 2018 Jun 4;13(6):e0198046. doi: 10.1371/journal.pone.0198046. eCollection 2018.
5
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.肠内分泌激素胰高血糖素样肽-2 的生理学和药理学。
Annu Rev Physiol. 2014;76:561-83. doi: 10.1146/annurev-physiol-021113-170317. Epub 2013 Oct 25.
6
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.胰高血糖素样肽-1 治疗化疗引起的黏膜炎。
Gut. 2013 Dec;62(12):1724-33. doi: 10.1136/gutjnl-2012-303280. Epub 2012 Oct 20.
7
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.外源性胰高血糖素样肽-2(GLP-2)可预防大鼠小肠化疗引起的黏膜炎。
Cancer Chemother Pharmacol. 2012 Jul;70(1):39-48. doi: 10.1007/s00280-012-1882-2. Epub 2012 May 22.
8
The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D.胰高血糖素样肽-2 在肿瘤坏死因子-α/放线菌素 D 诱导的小鼠肠损伤模型中对细胞凋亡、细胞增殖和氧化应激-抗氧化系统的作用。
Mol Cell Biochem. 2011 Apr;350(1-2):13-27. doi: 10.1007/s11010-010-0678-0. Epub 2010 Dec 14.
9
Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.基质金属蛋白酶可能是暗褐家鼠消化道粘膜炎发展的介质。
Exp Biol Med (Maywood). 2010 Oct;235(10):1244-56. doi: 10.1258/ebm.2010.010082. Epub 2010 Aug 3.
10
Wnt signaling in mitosis.有丝分裂中的 Wnt 信号传导。
Dev Cell. 2009 Dec;17(6):749-50. doi: 10.1016/j.devcel.2009.12.001.